EB5 Capital Litigates USCIS’ Recent EB-5 Filing Fee Increases

WASHINGTON, April 29, 2024 (GLOBE NEWSWIRE) — On April 22, 2024, EB5 Capital, along with Invest in the USA (IIUSA), the national EB-5 trade association serving the majority of active Regional Centers, and ten other Regional Centers, filed a lawsuit against the United States Citizenship and Immigration Services (USCIS). The lawsuit, Civitas Capital Group et al. vs. USCIS et al., was filed in the District Court for the Northern District of Texas and challenges the “Final Rule” issued by the Department of Homeland Security (DHS) that concerns government filing fees for EB-5 related petitions.

The Final Rule issued by DHS on January 31, 2024, which went into effect on April 1, 2024, revised USCIS’ filing fees for all petitions and applications adjudicated by the agency. Civitas Capital Group et al. vs. USCIS et al. argues that the fee increases for EB-5 related petitions in this Final Rule are far greater both in dollar amounts and in percentage increase compared to any of the other increases in filing fees announced in this rule. “It is essential that USCIS abide by the rule of law in promulgating regulations. Its ongoing failure to do so diminishes the impact and integrity of the EB-5 Program,” commented Lulu Gordon, General Counsel for EB5 Capital. The lawsuit argues that the new fee structure violates several federal laws, including the EB-5 Reform and Integrity Act of 2022 (RIA), the Regulatory Flexibility Act (RFA), the Immigration and Nationality Act (INA), and the Administrative Procedure Act (APA), as well as internal guidelines established by the Office of Management and Budget (OMB).

“These increased fees are unreasonable and will burden our current and future investors,” said Ishaan Khanna, EB5 Capital’s Director of Business Development. Ishaan Khanna’s non-profit organization, The American Immigrant Investor Alliance (AIIA), which advocates for EB-5 investors’ rights, previously filed a similar lawsuit against USCIS in March.

For more information, a copy Civitas Capital Group et al. vs. USCIS et al. is available here.

About EB5 Capital

EB5 Capital provides qualified foreign investors with opportunities to invest in job-creating commercial real estate projects under the United States Immigrant Investor Program (EB-5 Visa Program). Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. As one of the oldest and most active Regional Center operators in the country, the firm has raised over $1 billion of foreign capital across approximately 40 EB-5 projects. 100% of our investors’ funds are protected by the Federal Deposit Insurance Corporation (FDIC) insurance prior to their deployment into our projects. Please visit www.eb5capital.com for more information.  

Contact:
Katherine Willis
Director, Marketing & Communications
media@eb5capital.com

GlobeNewswire Distribution ID 9107671

Arqit announces collaboration to deliver out-of-the-box post-quantum cryptography solutions

LONDON, April 29, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today announced the creation of the World’s First Quantum-Safe, 1.89 Tb IPsec products collaborating with Intel.

Arqit and Intel have joined forces for out-of-the-box post-quantum cryptography solutions using Arqit’s Symmetric Key Agreement Platform (SKA-Platform™) running on Intel Xeon Scalable processors. Combining Intel technologies with Arqit’s SKA-Platform™ achieves high-performance IPsec encryption, protecting against quantum attacks without compromising speed.

To find our more, join the Intel and Arqit webinar on 30th April 2024 REGISTER

David Williams, Arqit Founder, Chairman and CEO said:
“Our collaboration with Intel delivers the groundbreaking introduction of the world’s inaugural quantum-safe, 1.89 Tb IPsec solution. Cyber threats continue to become more sophisticated, including the imminent advent of quantum computing, enterprises seek robust defences. Our joint effort with Intel provides off-the-shelf products that not only harden networks but also make them quantum-safe whilst adhering to core standards like RFC 8784.”

Notes to Editors

Arqit representatives will be attending RSA (6-9 May 2024) and will be available for interview. www.rsaconference.com/usa.

Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.

About Arqit

Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit) supplies a unique encryption software service which makes the communications links of any networked device, cloud machine or data at rest secure against both current and future forms of attack on encryption – even from a quantum computer. Compatible with NSA CSfC Components and meeting the demands of NSA CSfC Symmetric Key Management Requirements Annexe 1.2. and RFC 8784, Arqit’s Symmetric Key Agreement Platform uses a lightweight software agent that allows end point devices to create encryption keys locally in partnership with any number of other devices. The keys are computationally secure and facilitate Zero Trust Network Access. It can create limitless volumes of keys with any group size and refresh rate and can regulate the secure entrance and exit of a device in a group. The agent is lightweight and will thus run on the smallest of end point devices. The product sits within a growing portfolio of granted patents. It also works in a standards compliant manner which does not oblige customers to make a disruptive rip and replace of their technology. Arqit is winner of two GSMA Global Mobile Awards, The Best Mobile Security Solution and The CTO Choice Award for Outstanding Mobile Technology, at Mobile World Congress 2024, recognised for groundbreaking innovation at the 2023 Institution of Engineering and Technology Awards and winner of the National Cyber Awards’ Innovation in Cyber Award and the Cyber Security Awards’ Cyber Security Software Company of the Year Award. Arqit is ISO 27001 Standard certified. www.arqit.uk

Media relations enquiries:
Arqit: pr@arqit.uk

Investor relations enquiries:
Arqit: investorrelations@arqit.uk
Gateway: arqit@gateway-grp.com

Caution About Forward-Looking Statements

This communication includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These forward-looking statements are based on Arqit’s expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Arqit’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Arqit to predict these events or how they may affect it. Except as required by law, Arqit does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date this communication is issued. In light of these risks and uncertainties, investors should keep in mind that results, events or developments discussed in any forward-looking statement made in this communication may not occur. Uncertainties and risk factors that could affect Arqit’s future performance and cause results to differ from the forward-looking statements in this release include, but are not limited to: (i) the outcome of any legal proceedings that may be instituted against the Arqit, (ii) the ability to maintain the listing of Arqit’s securities on a national securities exchange, (iii) changes in the competitive and regulated industries in which Arqit operates, variations in operating performance across competitors and changes in laws and regulations affecting Arqit’s business, (iv) the ability to implement business plans, forecasts, and other expectations, and identify and realise additional opportunities, (v) the potential inability of Arqit to successfully deliver its operational technology, (vi) the risk of interruption or failure of Arqit’s information technology and communications system, (vii) the enforceability of Arqit’s intellectual property, and (viii) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Arqit’s annual report on Form 20-F (the “Form 20-F”), filed with the U.S. Securities and Exchange Commission (the “SEC”) on 21 November 2023 and in subsequent filings with the SEC. While the list of factors discussed above and in the Form 20-F and other SEC filings are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realisation of forward-looking statements.

GlobeNewswire Distribution ID 9107084

Deriv promotes Rakshit Choudhary from COO to co-CEO

Rakshit Choudhary promoted to co-CEO

Deriv promotes Rakshit Choudhary from COO to co-CEO

  • Rakshit Choudhary promoted to co-CEO, partnering with Founder and CEO Jean-Yves Sireau
  • Deriv refreshes its leadership model as it gets set to celebrate its 25th anniversary

    Rakshit Choudhary, co-CEO of Deriv

Rakshit Choudhary, co-CEO of Deriv

CYBERJAYA, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) — In a significant move for the online trading company, as it approaches its 25th anniversary, Deriv has announced the promotion of Rakshit Choudhary from Chief Operating Officer (COO) to co-Chief Executive Officer (co-CEO). The co-CEO model will capitalise on the different strengths and diverse perspectives of both leaders.

Choosing the co-model is not just a strategic move for Deriv. It lets the organisation incorporate diverse viewpoints and teamwork into critical decision-making to keep the business agile. This double leadership framework also creates an environment where reciprocal respect and shared accountability are standard practices and balances individual autonomy with a collective vision.

Jean-Yves Sireau, Founder and co-CEO of Deriv, said: “Rakshit is a great leader with a deep understanding of Deriv’s business, so his move to co-CEO is a natural step forward for us. It is like the synergy you see in pair programming—improved decision-making and better alignment of goals.

“Deriv turning 25 is a moment for reflection. Refreshing our leadership model makes us well-positioned to take on the next phase of Deriv’s business, which is focused on expanding globally and engaging more deeply with diverse markets. This dual leadership approach helps keep Deriv innovative and committed to excellent customer service and strong partnerships.”

Choudhary, who holds a Master’s degree from Georgia Institute of Technology, joined Deriv in 2009 as a Quantitative Analyst and then Head of Quantitative Development & Research. His next role at Deriv was Head of Product Development before his promotion to COO in 2018.

Rakshit Choudhary shared his thoughts on his new role: “I have been lucky to be part of Deriv’s incredible growth and evolution for the last 14 years, witnessing firsthand its mission to make trading accessible to anyone, anywhere. At the centre of this is a focus on staying innovative, secure, and accessible. I look forward to continuing to grow Deriv’s business globally alongside Jean-Yves, as we take the company into another successful 25 years.”

Deriv has also transitioned to a co-CFO model with Jennice Lourdsamy, previously Head of Accounts and Payments taking a double leadership role as co-CFO alongside Louise Wolf, the current CFO. The co-leadership mindset does not end at the C-level. It is practised across Deriv at all levels, in line with the company’s values of integrity, competence, customer focus, and teamwork.

Deriv remains committed to its principles of leadership excellence, marked by clear vision, result-oriented approaches, continuous learning, and a bias for action. These principles are embedded in daily operations and are critical to achieving Deriv’s mission of making advanced trading solutions accessible worldwide.

About Deriv

For 25 years, Deriv has been committed to making online trading accessible to anyone, anywhere. Trusted by over 2.5 million traders worldwide, the company offers an expansive range of trade types and boasts over 200 assets across popular markets on its award-winning, intuitive trading platforms. With a workforce of more than 1,400 people globally, Deriv has cultivated an environment that celebrates achievements, encourages professional growth, and fosters talent development, which is reflected in its Platinum accreditation by Investors in People.

PRESS CONTACT
pr@deriv.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2a2adfa8-5309-4a67-88cf-69d000020b5a

GlobeNewswire Distribution ID 9106564

Zahid Group is recognized as a “Top Employer in the Middle East for 2024”

“We start with integrity and end with excellence.”

Jeddah, Saudi Arabia, Zahid Business Park, April 25, 2024 (GLOBE NEWSWIRE) — On Thursday, 18 January 2024, Jeddah, Kingdom of Saudi Arabia: The Top Employers Institute recognized Zahid Group as a Top Employer in the Middle East for 2024, placing the group among the top 10% employers in KSA.

“We start with integrity and end with excellence.”

The Top Employers Institute is the global authority that recognizes excellence in people’s practices and helps accelerate them to enrich the world of work. It allows participating companies to be validated, certified, and recognized as employers of choice. Established over 30 years ago, the Top Employers Institute has certified 2,300 organizations in 121 countries/regions. These certified Top Employers positively impact the lives of over 9 million employees globally.

The certification was granted following an extensive assessment of the group’s integrated human resources practices across the examined International Companies in six domains and twenty sub-topics, thoroughly auditing the policies and practices. This achievement endorses Zahid Group’s shared values and best-in-class people practices, highlighting the areas for further improvement and development.

Amr W. Zawawi, The Group Human Resource Manager, said, “Being recognized as a “Top Employer in the Middle East for 2024” is a true testament to the Group’s passion for its people, commitment to its shared values, and dedication to excellence. This opportunity is worth seizing to congratulate all Zahid Group members and leadership for accomplishing this achievement; this will serve as an incentive to maintain the same approach, starting with integrity and ending with excellence.”

Attachment

Mohammad Halabi
Zahid Group
M.halabi@anotherintl.com

GlobeNewswire Distribution ID 9105833

ROSEN, A LEADING LAW FIRM, Encourages HireRight Holdings Corporation Investors to Secure Counsel in Securities Class Action – HRT

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of HireRight Holdings Corporation (NYSE: HRT) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with HireRight’s October 2021 initial public offering (the “IPO”), of the important June 3, 2024 lead plaintiff deadline.

SO WHAT: If you purchased HireRight securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the HireRight class action, go to https://rosenlegal.com/submit-form/?case_id=23874 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 3, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Offering Documents made false and/or misleading statements and/or failed to disclose that: (1) HireRight was exposed to customers with significant employment and hiring risk and HireRight derived greater revenue growth from existing client hiring than from new client hiring; (2) as a result, HireRight’s revenue growth was unsustainable to the extent that it relied on the stability of its current customers’ hiring and/or the profitability of securing new customers; (3) accordingly, HireRight had overstated its post-IPO business and/or prospects; and (4) as a result, defendants’ statements about HireRight’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the HireRight class action, go to https://rosenlegal.com/submit-form/?case_id=23874 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9105680

ROSEN, LEADING INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the “Class Period”), of the important June 4, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Checkpoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Checkpoint class action, go to https://rosenlegal.com/submit-form/?case_id=23997 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Checkpoint had overstated its oversight of, and/or its establishment of adequate manufacturing standards and controls over, its third-party contract manufacturers; (2) accordingly, there were one or more issues with Checkpoint’s third-party contract manufacturing organization (“CMO”) for cosibelimab, Checkpoint’s lead antibody product candidate; (3) all the foregoing reduced the likelihood that the Federal Drug Administration would approve the cosibelimab Biologics License Application (“BLA”) in its present form; (4) as a result, the manufacturing, regulatory, and commercial prospects of cosibelimab were overstated; and (5) as a result, Checkpoint’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Checkpoint class action, go to https://rosenlegal.com/submit-form/?case_id=23997 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 9105665